Stifel Starts Establishment Labs Coverage With Buy Rating, $84 Target

Enna Lee

1 min read

Stifel Starts Establishment Labs Coverage With Buy Rating, $84 Target

The firm pointed to growth potential in the breast augmentation market. Establishment Labs shares gained in Thursday trading.

By Enna Lee

Published Oct 15, 2026, 8:22 PM EDT

A silicone implant rests on a sculpted terracotta pedestal / TokenPost.ai

Establishment Labs Holdings Inc. (NASDAQ: ESTA) gained in Thursday trading as Stifel opened analyst coverage of the breast implant maker, assigning its shares a Buy rating and an $84 price target.

Stifel’s rationale was its assessment of the breast augmentation market’s growth outlook.

Enna Lee

Reporter

Enna Lee reports on investing and digital-asset markets for TokenPost. Send corrections or tips to info@tokenpost.com.